Special considerations in treating the elderly patient with epilepsy

Area of Science:

• Geriatric Medicine
• Neurology
• Clinical Pharmacology

Background:

• Epilepsy in the elderly differs from younger populations in cause, symptoms, and outcome.
• Aging brings physiological changes and increased vulnerability to adverse drug events.
• Elderly patients often have comorbidities and polypharmacy, increasing risks for drug interactions and toxicity.

Purpose of the Study:

• To compare the efficacy and safety of newer antiepileptic drugs (AEDs) versus older AEDs in elderly epilepsy patients.
• To provide data to educate physicians on selecting appropriate AEDs for older individuals.
• To highlight the importance of informed AED selection for optimal seizure control and minimal adverse events in the elderly.

Main Methods:

• Review of clinical trial data comparing newer-generation AEDs with older AEDs in elderly populations.
• Analysis of efficacy and safety profiles of various AEDs.
• Consideration of findings from the Veterans Affairs Cooperative Study (VACS) #428.

Main Results:

• Newer AEDs offer a potentially improved balance of efficacy and safety in elderly patients.
• Specific data from clinical trials and VACS #428 inform the comparative performance of different AEDs.
• Understanding drug-drug interactions and age-related vulnerabilities is crucial for interpreting results.

Conclusions:

• The choice of antiepileptic drugs (AEDs) for elderly patients requires careful consideration of age-specific factors.
• Newer AEDs may provide better seizure control with reduced adverse events compared to older medications.
• Physician education on AED selection is vital for optimizing treatment outcomes in geriatric epilepsy.